Search research articles
Contact Us
Filters
Showing results (71-80 of 116) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Investigation
|
November 16, 2013
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression
Sarah Ann R Anderson, Michael Michaelides, Parisa Zarnegar, et al.
Scientific Reports
|
January 22, 2024
Synthesis and preclinical evaluation of [<sup>11</sup>C]uPSEM792 for PSAM<sup>4</sup>-GlyR based chemogenetics
Sridhar Goud Nerella, Sanjay Telu, Jeih-San Liow, et al.
Molecular Imaging and Biology
|
August 23, 2022
6-O-(2-[<sup>18</sup>F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([<sup>18</sup>F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo
Marjorie R Levinstein, Emilya N Ventriglia, Juan L Gomez, et al.
Biological Psychiatry
|
February 25, 2023
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R Levinstein, Meghan L Carlton, Tommaso Di Ianni, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
D2 autoreceptors gate vulnerability to cocaine use disorder
Erin M Murray, Daniel Diaz-Urbina, Roland Bock, et al.
Neuroendocrinology
|
November 6, 2008
Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity
Lisa M Davis, Michael Michaelides, Lawrence J Cheskin, et al.
The European Journal of Neuroscience
|
May 8, 2019
Ultrastructural localization of DREADDs in monkeys
Adriana Galvan, Jessica Raper, Xing Hu, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability
Philip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Molecular Psychiatry
|
April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Jordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Science (New York, N.Y.)
|
August 5, 2017
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Juan L Gomez, Jordi Bonaventura, Wojciech Lesniak, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 116) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Investigation
|
November 16, 2013
Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression
Sarah Ann R Anderson, Michael Michaelides, Parisa Zarnegar, et al.
Scientific Reports
|
January 22, 2024
Synthesis and preclinical evaluation of [<sup>11</sup>C]uPSEM792 for PSAM<sup>4</sup>-GlyR based chemogenetics
Sridhar Goud Nerella, Sanjay Telu, Jeih-San Liow, et al.
Molecular Imaging and Biology
|
August 23, 2022
6-O-(2-[<sup>18</sup>F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([<sup>18</sup>F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo
Marjorie R Levinstein, Emilya N Ventriglia, Juan L Gomez, et al.
Biological Psychiatry
|
February 25, 2023
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability
Marjorie R Levinstein, Meghan L Carlton, Tommaso Di Ianni, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
D2 autoreceptors gate vulnerability to cocaine use disorder
Erin M Murray, Daniel Diaz-Urbina, Roland Bock, et al.
Neuroendocrinology
|
November 6, 2008
Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity
Lisa M Davis, Michael Michaelides, Lawrence J Cheskin, et al.
The European Journal of Neuroscience
|
May 8, 2019
Ultrastructural localization of DREADDs in monkeys
Adriana Galvan, Jessica Raper, Xing Hu, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability
Philip J Hajduk, Suzanne B Shuker, David G Nettesheim, et al.
Molecular Psychiatry
|
April 16, 2021
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Jordi Bonaventura, Sherry Lam, Meghan Carlton, et al.
Science (New York, N.Y.)
|
August 5, 2017
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Juan L Gomez, Jordi Bonaventura, Wojciech Lesniak, et al.
Page
of 12